Hereditary Angioedema
📧 Sign up to get email alerts when something new happens for Hereditary Angioedema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-04-05Clinical Trial Update: A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor [Phase 1]
A Phase 1 study completed evaluating the safety and pharmacokinetics of two formulations of C1-esterase inhibitor for hereditary angioedema,…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [Phase 2, Phase 3]
Clinical trial update on recombinant human C1 inhibitor (Ruconest) for acute attacks in hereditary angioedema, covering Phase 2/3 studies wi…
-
CLINICAL_TRIALS trial_result · 2013-01-31Clinical Trial Update: A Study of the Safety and Immunogenicity of Repeated rhC1INH Administration [Phase 2]
Phase 2 results report safety and immunogenicity of repeated administration of recombinant human C1 esterase inhibitor in hereditary angioed…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase [Phase 2]
Phase 2 study evaluating safety and pharmacology of subcutaneous CINRYZE with recombinant human hyaluronidase in hereditary angioedema has c…
-
CLINICAL_TRIALS trial_result · 2012-12-28Clinical Trial Update: Safety and Efficacy Study of Repeated Doses of DX-88 (Ecallantide) to Treat Attacks of Hereditary Angioedema (HAE) [Phase 3]
Phase 3 trial update evaluating repeated doses of ecallantide (DX-88) for treatment of attacks in hereditary angioedema (HAE).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [Phase 2, Phase 3]
Complete Phase 2 and Phase 3 trial updates for recombinant human C1 esterase inhibitor in treating acute attacks of hereditary angioedema, w…
-
CLINICAL_TRIALS trial_result · 2012-08-30Clinical Trial Update: Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema [Phase 3]
Phase 3 trial evaluating recombinant human C1 esterase inhibitor for acute attacks in hereditary angioedema has completed with results poste…
-
CLINICAL_TRIALS trial_result · 2012-03-08Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration [Phase 2]
Phase 2 trial update evaluating safety, PK, and PD of subcutaneous CINRYZE in hereditary angioedema has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2011-06-23Clinical Trial Update: C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study) [Phase 3]
A Phase 3 extension study of a C1 esterase inhibitor for hereditary angioedema has completed, with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-01-19Clinical Trial Update: Berinert P Study of Subcutaneous Versus Intravenous Administration [Phase 3]
Phase 3 clinical trial comparing subcutaneous versus intravenous administration of Berinert P for hereditary angioedema has completed.
-
CLINICAL_TRIALS trial_result · 2010-08-24Clinical Trial Update: Human C1 Esterase Inhibitor (C1-INH) in Subjects With Acute Abdominal or Facial Hereditary Angioedema (HAE) Attacks [Phase 2, Phase 3]
This clinical trial update reports the completion and results posting of Phase 2 and Phase 3 trials evaluating human C1 esterase inhibitor (…
-
CLINICAL_TRIALS trial_result · 2010-06-09Clinical Trial Update: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks [Phase 3]
Phase 3 open-label trial of C1 esterase inhibitor (C1INH-nf) for acute hereditary angioedema attacks completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-06-03Clinical Trial Update: C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks [Phase 3]
Phase 3 trial evaluating C1 esterase inhibitor for prevention of acute attacks in hereditary angioedema has completed with results posted in…
-
CLINICAL_TRIALS trial_result · 2010-06-02Clinical Trial Update: C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks [Phase 3]
Phase 3 trial update for C1 Esterase Inhibitor (C1INH-nf) in acute hereditary angioedema attacks has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2010-05-11Clinical Trial Update: Efficacy and Safety Study of DX-88 to Treat Acute Attacks of Hereditary Angioedema (HAE) [Phase 3]
Phase 3 trial update for DX-88 evaluating efficacy and safety in treating acute attacks of hereditary angioedema (HAE) has completed with re…
-
CLINICAL_TRIALS trial_result · 2010-05-04Clinical Trial Update: Efficacy Study of DX-88 (Ecallantide) to Treat Acute Attacks of Hereditary Angioedema (HAE) [Phase 3]
Phase 3 trial evaluating DX-88 (ecallantide) for acute attacks of hereditary angioedema has completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-05-03Clinical Trial Update: Open-Label C1 Esterase Inhibitor (C1INH-nf) for the Prevention of Acute Hereditary Angioedema (HAE) Attacks [Phase 3]
Phase 3 open-label trial evaluating C1 esterase inhibitor (C1INH-nf) for prevention of acute attacks in hereditary angioedema completed with…
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: Kinetics, Efficacy and Safety of C1-Esteraseremmer-N [Phase 2]
Phase 2 trial results for C1-Esteraseremmer-N assess kinetics, efficacy, and safety in hereditary angioedema. The study is reported as compl…
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema [Phase 3]
Phase 3 clinical trial update for C1-Esteraseremmer-N in hereditary and acquired angioedema; the study has completed.
-
CLINICAL_TRIALS trial_result · 2009-05-04Clinical Trial Update: C1-Esteraseremmer-N for the Treatment of Hereditary (and Acquired) Angioedema [Phase 2, Phase 3]
Clinical trial update indicating completion of Phase 2 and Phase 3 studies of C1-Esteraseremmer-N for hereditary and acquired angioedema, sp…